Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for inflammation and pain in cataract surgery
NCT00524264Phase 3Completed
- Sponsor
- Allergan
- Start
- Oct 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketorolac tromethamine in post-operative inflammation, postoperative pain, sponsored by Allergan. Started Oct 2007; status: completed.
02
Drugs
ketorolac tromethamine
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT00524264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524264.